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The detailed analysis of 411 strains of coagulase-negative staphylococci (CoNS) obtained from 40 neutro-
penic hemato-oncologic patients (61 Hickman catheter episodes) on intensive chemotherapy is described. By
random amplification of polymorphic DNA (RAPD) analysis, a total of 88 different genotypes were detected: 51
in air samples and 30 in skin cultures prior to insertion, 12 in blood cultures after insertion, and only 5
involved in catheter-related infections (CRI). Two RAPD genotypes of Staphylococcus epidermidis predominated,
and their prevalence increased during patient hospitalization. At insertion, these clones constituted 11 of 86
(13%) CoNS isolated from air samples and 33 of 75 (44%) CoNS isolated from skin cultures. After insertion,
their combined prevalence increased to 33 of 62 (53%) in catheters not associated with CRI and 139 of 188
(74%) in catheters associated with CRI (P 5 0.0041). These two predominant S. epidermidis clones gave rise to
a very high incidence of CRI (6.0 per 1,000 catheter days) and a very high catheter removal rate for CRI, 70%,
despite prompt treatment with vancomycin. A likely source of S. epidermidis strains involved in CRI appeared
to be the skin flora in 75% of cases. The validity of these observations was confirmed by pulsed-field gel
electrophoresis (PFGE) of SmaI DNA macrorestriction fragments of blood culture CoNS isolates. Again, two
predominant CoNS genotypes were found (combined prevalence, 60%). RAPD and PFGE yielded concordant
results in 75% of cases. Retrospectively, the same two predominant CoNS clones were also found among blood
culture CoNS isolates from the same hematology department in the period 1991 to 1993 (combined prevalence,
42%) but not in the period 1978 to 1982. These observations underscore the pathogenic potential of clonal
CoNS types that have successfully and persistently colonized patients in this hemato-oncology department.
Coagulase-negative staphylococci (CoNS) have become the
most frequently isolated pathogens in intravascular catheter-
related infections (CRI), accounting for an estimated 28% of
all nosocomial bloodstream infections reported to the National
Nosocomial Infections Surveillance System from 1986 through
1989 (3, 16, 30). The emergence of CoNS as the primary patho-
gen causing CRI has been attributed to the increased use of
prosthetic and indwelling devices, the increased use of paren-
teral nutrition, and the improved survival of the immunocom-
promised host. In addition, CoNS have been recognized as
potentially true nosocomial pathogens rather than harmless
culture contaminants not worthy of being reported back from
the laboratory to the attending physicians (3, 9, 10). In hemato-
oncologic patients, the effective application of antibiotic pro-
phylaxis has facilitated the introduction of more aggressive
chemotherapies that have further increased the risk of septi-
cemia by CoNS (35).
Earlier CoNS-genotyping studies have shown persistence of
a few CoNS strains in various wards of our hospital. In 1993,
more than 30% of CoNS from blood cultures taken from a
heart-lung machine during cardiac surgery belonged to a single
genotype (33). Furthermore, it was shown that certain CoNS
strains permeate the hematology department and colonize its
personnel. A number of hemato-oncologic patients were per-
sistently colonized by a single type; from others, however, mul-
tiple strains of CoNS were isolated (34). In another controlled
study, a high incidence of Hickman CRI due to CoNS in
neutropenic patients was demonstrated in the same hematol-
ogy department (2, 24).
The goal of the present study was to determine prospectively
the molecular epidemiology of CoNS involved in CRI within
a group of neutropenic hemato-oncologic patients at a large
university hospital in The Netherlands. Phenotypic and geno-
typic typing strategies were used to identify the clonal related-
ness of the CoNS strains involved.
(Part of this research was presented at the 36th Interscience
Conference on Antimicrobial Agents and Chemotherapy, New
Orleans, La., 15 to 18 September 1996 [23].)
MATERIALS AND METHODS
Patients and materials. All consecutive hemato-oncological patients receiving
intensive chemotherapy between August 1994 and April 1996 were included in
the study. Informed consent was obtained from all patients or their parents or
guardians, and the study protocol was reviewed and approved by the local
medical ethics committee. All patients were fitted with a bilumen Hickman
central venous catheter and received antimicrobial prophylaxis with ciprofloxacin
and fluconazole. Catheters were inserted under strict aseptic conditions with
sonographic and fluoroscopic guidance (17, 27). Hickman CRI were defined as
described previously (24).
Culturing. Cultures from different sites were taken regularly according to the
following scheme. (i) Before skin disinfection with 0.5% chlorhexidine in 70%
ethanol, cultures were taken from the skin at the insertion site and from air
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samples. After insertion but prior to closure of the wound, two exit site cultures
were taken. (ii) During hospitalization, serial cultures from the exit site, hub
interiors, and blood cultures drawn directly from both Hickman catheter chan-
nels were taken twice weekly. (iii) In case of fever, extra cultures from the exit
site and hub interiors plus at least two blood culture sets each via both Hickman
catheter channels and a peripheral vein were taken. As long as fever persisted,
these investigations were performed daily. (iv) When indicated, the Hickman
catheter was removed by a surgeon and the tip, tunnel, and hub segments were
cultured separately.
Isolation and identification of CoNS. Skin, exit site, hub, and air sample
culturing was performed according to standard procedures (14). For blood cul-
turing, the BACTEC 9240 system (Becton Dickinson Diagnostic Instrument
Systems, Sparks, Md.) was used. Tip and tunnel segments of removed Hickman
catheters were cultured by the semiquantitative roll-plate technique described by
Maki et al. (20). Tip, tunnel, and hub segments of removed Hickman catheters
were cultured quantitatively after flushing according to Linares et al. (18). All
three segments were also cultured in serum broth. Isolates were identified as
CoNS based on catalase and tube coagulase tests. CoNS were identified to
species level by using the API-Staph 32 test (bioMerieux, Lyon, France) (14).
CoNS isolated from clinical materials only, i.e., exit site skin, blood cultures, and
removed catheters, were tested for antibiotic susceptibility with the Vitek system
(bioMerieux Vitek, Hazelwood, Mo.). MICs were determined by E test (AB
Biodisk, Solna, Sweden). Strains were categorized as resistant, intermediately
sensitive, or sensitive to the antibiotic used based on National Committee for
Clinical Laboratory Standards breakpoints (21). All CoNS isolates were stored at
270°C in glycerol-containing liquid media.
Analysis of genetic relatedness of CoNS. To obtain bacterial DNA for analysis,
CoNS strains were grown overnight at 37°C on brucella blood agar. Between two
and five colonies were suspended in a 150-ml solution containing (per liter) 25
mmol of Tris-HCl (pH 8.0), 10 mmol of EDTA, and 50 mmol of glucose. To
prepare spheroplasts, 75 ml of a lysostaphin solution (100 mg/ml in water) was
added. After incubation at 37°C for 1 h, DNA was isolated according to the
protocol described previously (5). The final volume of the DNA solution con-
taining 10 mmol of Tris-HCl (pH 8.0) per liter and 1 mmol of EDTA per liter was
100 ml. The concentration of the purified DNA was determined and adjusted to
approximately 10 ng per ml. DNA preparations were stored at 220°C.
According to current recommendations, two techniques were used to type
staphylococci at the genotypic level (33, 34). First, all available CoNS isolates
from air sample, insertion site skin, exit site, hub, blood, and catheter cultures
were genotyped by PCR-based random amplification of polymorphic DNA
(RAPD). Analysis of amplification fragment length polymorphisms was per-
formed essentially as described previously (32). Arbitrarily primed PCR was
performed with Taq DNA polymerase (0.2 U per assay) (Sphaero Q, Leiden, The
Netherlands) in the accompanying buffer system, 0.2 mmol of the respective
deoxynucleoside triphosphates per liter and 50 pmol of primer. DNA (50 ng) was
added and the mixtures were overlaid with mineral oil. Primers used were the
oligonucleotides ERIC 1 and ERIC 2, having the following nucleotide se-
quences, respectively: 59-TGTAAGCTCCTGGGGATTCAC-39 and 59-AAGTA
AGTGACTGGGGTGAGCG-39. These primers are deduced from enterobac-
terial repetitive intergenic consensus sequences (36). Cycling (40 times for 1 min
at 94°C, 1 min at 25°C, and 2 min at 74°C) was performed in a BioMed model 60
thermocycler (BioMed, Theres, Germany). Analysis of reaction products was by
gel electrophoresis in 1 to 2% agarose gels submerged in 0.53 Tris-borate-
EDTA (TBE) buffer (28) and subsequent photography with a Polaroid Land
camera and high-speed Polaroid sheet film. Data were interpreted by three
independent observers, after which consensus was pursued based on additional
experimental data or interobserver discussion. Unique DNA banding patterns
were indexed with capital letters. When two fingerprints differed with respect to
single DNA band-staining intensity only, the same letter was used but a prime
was added to the second (e.g., A and A9).
In addition, pulsed-field gel electrophoresis (PFGE) was subsequently per-
formed on all bloodstream CoNS isolates available from patients. For purposes
of comparison, available bloodstream CoNS isolates from hemato-oncologic
patients admitted to the same hematology department in the periods 1978 to
1982 and 1991 to 1993 were also genotyped by PFGE. PFGE was carried out
based on protocols previously described for DNA from Staphylococcus aureus
(12, 25). A suspension of bacteria was mixed in a 1:1 ratio with 1% InCert
agarose (FMC Bioproducts, Rockland, Maine). Agarose plugs were prepared
with Bio-Rad (Veenendaal, The Netherlands) casting forms and incubated with
lysostaphin (Sigma Chemical Co., St. Louis, Mo.). Spheroplasts were lysed by
incubation of the plugs in buffer containing 1% sodium dodecyl sulfate and 1 mg
of proteinase K (Boehringer, Mannheim, Germany) per ml. Plugs were washed
six times for 30 min each in a solution containing 10 mmol of Tris-HCl (pH 8.0)
per liter and 1 mmol of EDTA per liter and stored at 4°C. DNA from half of a
plug was digested by SmaI (Boehringer), and PFGE was carried out in 1%
SeaKem GTG agarose gels (FMC Bioproducts). The buffer consisted of 0.53
TBE; the temperature was set at 14°C. Electrophoresis was performed in a
Bio-Rad CHEF Mapper. Running time was 22 h, with linear ramping from 2.16
to 44.69 s at an angle of 120° (60°/260°). The voltage was 6 V/cm, and gel
dimensions were 120 by 140 by 5 mm. Gels were stained with ethidium bromide
and photographed with instant Polaroid equipment. Differences in banding pat-
terns were documented by at least two independent observers. Genotypes were
defined on the basis of identity of the DNA banding patterns. Subtypes differed
in the positions of one or two restriction fragments only (34).
RESULTS
In total, 411 CoNS isolates from 61 episodes of Hickman
catheter employment in 40 consecutive patients were collected:
389 (95%) belonged to the species Staphylococcus epidermidis;
strains of Staphylococcus haemolyticus, Staphylococcus hominis,
and Staphylococcus warneri were incidentally isolated. Thirty-
six different antibiotic susceptibility patterns were determined:
71% of strains isolated were resistant to methicillin, 89%
to penicillin, 55% to gentamicin, 71% to ciprofloxacin, 87% to
sulfamethoxazole-trimethoprim, 81% to erythromycin, 56% to
clindamycin, 20% to rifampin, and 51% to tetracycline. All
were vancomycin susceptible. The majority of strains were
resistant to five or more antibiotics.
By RAPD, a total of 88 different genotypes of CoNS were
found. However, two genotypes of S. epidermidis (types A-A
and A-D) predominated. Their combined prevalence in-
creased from 13% at insertion (air sample cultures) to 74%
after insertion in catheters associated with CRI (Fig. 1). Their
combined prevalence differed significantly between catheters
associated with CRI and those not associated with CRI (139 of
188 [74%] and 33 of 62 [53%], respectively [P 5 0.0041]).
When only blood culture isolates (n 5 148) were considered,
their combined prevalence rates were 9 of 23 (39%) and 84 of
125 (67%), respectively (P 5 0.017 [Fisher’s exact test]). In six
of eight catheters (75%) removed because of CRI and yielding
positive catheter tip cultures, types A-A and/or A-D were dem-
onstrated (Table 1).
The diversity in CoNS genotypes decreased inversely from
51 among isolates from air sample cultures to 8 in exit site skin
cultures from catheters with CRI (Fig. 1). Twenty-three differ-
ent S. epidermidis genotypes were isolated after insertion: 17 in
catheters not associated with CRI and 11 in catheters associ-
ated with CRI. In blood culture isolates, 17 different genotypes
of S. epidermidis were detected: 11 in catheters not associated
with CRI and 9 in catheters associated with CRI. Only four
different genotypes of S. epidermidis were isolated from the
surfaces of removed catheters (Table 1). Antibiotic suscepti-
bility patterns varied widely, even within single RAPD geno-
types. For example, within RAPD genotype A-A, 20 different
antibiotic susceptibility patterns were discerned, while within
RAPD genotype A-D, 16 patterns were distinguished. The
prevalences of methicillin resistance among RAPD genotypes
A-A and A-D were 62.5 and 76%, respectively. Both penicillin
and ciprofloxacin resistance was found in 94% of A-A strains
and in 90% of A-D strains.
Twenty CRI episodes were encountered in 18 patients: 10
bacteremias (RAPD types A-A [5], A-D [2], A-EE [1], F-E [1],
and A-A plus C-C [1]), 6 local infections (A-A [1], A-D [1],
A-EE [1], and no positive cultures [3]), and 4 combined infec-
tions (A-A [1], A-D [2], and A-A plus A-D [1]). Thus, only five
different RAPD genotypes of S. epidermidis (A-A [8], A-D [6],
A-EE [2], F-9E [1], and C-C [1]) were involved in these 20 CRI
episodes (Table 1; Fig. 2). RAPD genotypes N-D, F-Q, and
JJ-FF were considered not relevant, since they were each iso-
lated only once. In 15 of these 20 (75%) episodes the skin was
very likely to be the source of these S. epidermidis isolates;
there were 10 local infections (with or without bacteremia),
and in 5 of 10 “pure” bacteremias the same RAPD genotype
was cultured from blood as from exit site skin before the onset
of infection (Table 1).
In 13 catheter episodes in 13 patients, positive blood cultures
(contamination or colonization) were obtained in the absence
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of signs or symptoms of CRI. In these episodes, 11 different
RAPD genotypes of S. epidermidis (A-A [2], A-D [4], A-EE
[1], AA-D [1], F-E [1], F-N [1], F-U [1], R-GG [1], T-I [1], W-B
[1], and Z-E [1]) were found. In 5 of the 13 cases, the RAPD
genotype found in the blood was demonstrated on skin before-
hand (Table 1).
The prospective positive and negative predictive values
(PV1 and PV2, respectively) of the serial surveillance cul-
tures for subsequent development of CRIs were low: hub
PV1, 33%; hub PV2, 63%; exit site PV1, 33%; exit site PV2,
68%; and for blood cultures via the Hickman catheter, PV1
was 55% and PV2 was 88%. Also, colonization with RAPD
genotypes A-A and/or A-D did not predict the development of
CRI: these clones were isolated from skin or exit sites in 11 of
20 catheters associated with CRI before the onset of infection
versus 15 of 41 catheters not associated with CRI (odds ratio,
2.12 [95% confidence interval, 0.715 to 6.28]; P 5 0.27).
Among the 14 RAPD genotypes of S. epidermidis isolated
from 30 catheter episodes with positive blood cultures (17 CRI
and 13 non-CRI), 15 different PFGE genotypes were detected.
As with RAPD, with PFGE two predominant genotypes of S.
epidermidis were found: type B was isolated in 12 of 30 (40%)
catheter episodes, and type D was isolated in 8 of 30 (27%)
catheter episodes (Table 1; Fig. 3). These predominant geno-
types of S. epidermidis persisted throughout the whole study
period. Four different PFGE genotypes of S. epidermidis were
distinguished among both RAPD genotype A-A (11 genotypes
in 10 catheters: B [1], D [7], I [2], and J [1]), and genotype
A-EE (4 genotypes in 3 catheters: B [1], D [1], P [1], and Q
[1]), while RAPD genotype A-D could not be subtyped further
(n 5 10 [all PFGE type B]). PFGE genotypes B, D, I, J, P, and
Q were confined to RAPD genotypes A-A, A-D, and A-EE.
PFGE type K consisted of three different RAPD genotypes
(F-Q, F-U, and JJ-FF). RAPD genotype F-E was PFGE typed
as A once and as L twice. The seven other RAPD genotypes
coincided with one unique PFGE type (Table 1).
Blood culture CoNS isolates from hemato-oncologic pa-
tients admitted to the same hematology department in the
periods 1978 to 1982 and 1991 to 1993 were subsequently
genotyped by PFGE (one blood culture isolate per genotype
per catheter episode). Seventeen PFGE genotypes were found
in 27 CoNS isolates from the period 1978 to 1982. No predom-
inant genotypes seemed to be present at that time, and all were
genotypically different from the CoNS isolates from the
present study. Twenty-three PFGE genotypes were found in 42
CoNS isolates from the period 1991 to 1993. The same two
PFGE genotypes (B and D) of S. epidermidis found to be
predominant in patient cultures from August 1994 to April
1996 were also found to be present in the period 1991 to 1993.
Their combined prevalence has risen from 43% in 1991 to 1993
to 60% in 1994 to 1996 (Fig. 4).
DISCUSSION
CoNS strains have been implicated frequently in infectious
diseases in various groups of patients, although mostly in ne-
onates (13, 15, 22, 33, 34). Persistence of multiresistant strains
for prolonged periods has been documented in neonatal inten-
sive care units, suggesting that cross-infections occur regularly
(15, 19). Molecular epidemiology of CoNS from blood isolates
of neonates with persistent bacteremia has revealed that CRI
may be caused persistently by a single strain of CoNS (22, 31).
Another study considering CRI by CoNS described coloniza-
tion and subsequent infection by CoNS strains unique to indi-
vidual patients (8).
In the present study, it was demonstrated that two clones of
S. epidermidis were predominantly involved in colonization and
subsequent infection in neutropenic hemato-oncologic pa-
tients in a setting with a high incidence of CRI (6.0 per 1,000
catheter days). These two clones were responsible for more
than 70% of CRI, and they seem to have persisted for a period
of at least 5 years in our hematology department (34). How-
ever, colonization itself with one of the two predominant
clones could not predict the development of a CRI. Further-
more, these two predominant clones appear to be confined to
the hematology department so far, since their PFGE patterns
were shown to be totally different from those of CoNS isolated
earlier in the cardiopulmonary surgery department and other
departments of our hospital (33).
At insertion, RAPD genotypes A-A and A-D of S. epider-
FIG. 1. Distribution of RAPD genotypes of CoNS during Hickman catheter usage in hemato-oncologic patients. Eighty-eight RAPD genotypes among 411 CoNS
isolates from 61 Hickman catheter episodes in 40 patients were detected. Each sector of an individual pie chart represents the contribution of a single RAPD CoNS
genotype to the total number of CoNS isolated at the indicated time, site, and infection status. †, number of strains/number of RAPD genotypes isolated; ‡, two-letter
codes correspond to codes in Table 1 while numbers are the numbers of strains isolated; §, number of single unique RAPD genotypes isolated at the indicated time,
site, and infection status; ¶, number of catheter episodes at the indicated time and infection status.
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TABLE 1. Chronological array of bloodstream CoNS isolates together with genotypically related isolates from air samples,
skin, exit sites, and catheter hubsa
Patient
RAPD type
(ERIC 1-
ERIC 2)
PFGE type Chronological isolation of CoNS from different sites afterHickman catheter insertionb
CRI
1 F-E A FF n
I 111111111 R§
7 A-A Icath I, Dcath II Eh hF Eh hFFF
I 111111111111 R§ I 111111111 R§
C-C G FFFF n
8 A-D B FFFFn
I 111111111111111111111111111111111111 R§
9cath I A-D B h FFhFFn
I111111111 R§
A-A n
10 A-A D FFn
I 1111111111111111111 R§
13 A-A Icath I, J 1 Bcath II Ehh h h hFFFh h FFhFhåFFF
I 11111111111111 R§¶ I 111111111111111111 R§
F-Q K F
15 A-A D Eh h h FF F
I 1111111111111 R§
17 A-A D Eh h h FFFF
I 111111111111 R§
F-E L FF
31 A-EE B 1 D FFF
I 11111111111111111111 R§
JJ-FF K F
5 A-A D E h h hhhhhFh
I 1111111111111111111111111111111111111111111111111 NR¶
12 A-D B h F
I 1111111111111111111111111111111111111111111111111 NR¶
35cath I A-EE Q h FFF h
I 11111111111 R¶
2 A-D B h å F h h F F F n
I 111111111111 R§¶
4 A-D B F F n
I 1111111 R§¶
A-A h h n
6 A-D B FF n
I 1111 R§¶
CC or BCCc
3 A-D B hF n
I 11111111111 NR\
9cath II A-D B h F F
I 111111111111111111111 NR\
16 A-A D F
I 1111111111111111111111111111111111111111111111111 NR\
F-N L F
19 F-U K F
I 1111111111111111111111111111111111111111111111111 NR\
20 T-I M F
I 1111111111111111111111111111 NR\
22 A-D B h h F F
I 1111111111111111111111111111111111111111111111111 NR\
23 F-E L F
I 1111111111111111111111111111111111111111111111111 NR\
24 A-D B h F
I 1111111111111111111111111111111111111111111111111 NR\
Continued on following page
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midis were found in 13% of air sample cultures and in 44% of
skin cultures. During Hickman catheter employment, the prev-
alence rates of these clones were significantly higher in cathe-
ters associated with CRI than in catheters not associated with
CRI (74 and 53%, respectively [P 5 0.0041]). At removal,
these two clones were isolated in 78% of cases. Thus, their
prevalence increased during hospitalization, making it very
likely that acquisition by cross-contamination in the hematol-
ogy department occurred frequently. The air of the radiology
suite probably became contaminated by CoNS present on the
skin of patients under treatment. Furthermore, most Hickman
catheters were inserted at the end of the first week following
admittance to the hematology department, according to the
hemato-oncologic workup protocol. This probably explains
why, at the time of Hickman catheter insertion, 44% of pa-
tients were already carrying these two clones on their (inser-
tion site) skin. Further genotyping studies of CoNS from the
skin of ward-related personnel and air samples from the he-
matology department, as well as skin cultures from patients
upon admittance, are needed to elucidate the transmission
routes taken by these strains. However, the skin of the two
intervention radiologists inserting all Hickman catheters was
free of these two predominant clones of S. epidermidis or any
of the other S. epidermidis strains involved in CRI (results not
shown).
Besides the fact that these two clones were very predomi-
nant, they were possibly also more virulent than other CoNS,
since a very high rate of CRI (6.0 per 1,000 catheter days) has
been reported from this hematology department, and, impor-
tantly, nearly 70% of catheters associated with developed CRI
TABLE 1—Continued
Patient
RAPD
type
(ERIC
1-ERIC 2)
PFGE type Chronological isolation of CoNS from different sites afterHickman catheter insertionb
25 Z-E N F
I 1111111111111111111111111111111111111111111111111 NR\
26 A-A D F
I 1111111111111111111111111 NR\
AA-D O F
33 A-EE P h hFhF F
I 1111111111111111111111111111111111111111111111111 NR\
35cath II R-GG R FF
I 11111111111111111111111111 NR\
40 W-B E F F
I 1111111111111111111111111111111111111111111111111 NR\
a Isolates from 30 catheter episodes (26 patients) with positive CoNS blood cultures, 20 catheter episodes (18 patients) defined as CRI (17 with positive blood cultures
and 3 localized infections without positive blood cultures [not shown]), and 10 catheter episodes defined as catheter colonization or blood culture contamination. One
CoNS isolate per day per culture site is shown. Catheter episodes without positive blood cultures are not shown, and genotypically nonrelated CoNS isolates from air
samples, skin/exit sites and hubs are not shown.
b §, catheter-related bloodstream infection; ¶, catheter-related local infection; \, no CRI; I, insertion; R, removed for infection; NR, not removed for infection; 111,
1 week; E, air sample culture; h, skin/exit site culture; å, hub culture; F, blood culture; n, tip culture.
c Catheter colonization or blood culture contamination.
FIG. 2. RAPD analysis of CoNS isolated from patients fitted with Hickman catheters. For patient 9 (A and B), eight strains derived from blood cultures were
analyzed in two separate assays with two different primer species in RAPD (ERIC 1 and ERIC 2), as indicated below the panels. The patient was sampled daily for
a full week, and all blood samples were culture positive for CoNS. After catheter removal, catheter tip cultures were also found to be positive. All RAPD fingerprints
obtained were identical, demonstrating persistent infection by a single genotype (predominant strain A-D [see also Table 1]). For comparison, panel C displays typing
data for strains derived from patient 18. Increased diversity in ERIC 2 fingerprints is shown. Strains were obtained from the catheter exit site, skin, and urine on various
occasions spanning a period of more than 3 months. Lanes M display molecular length markers (100-bp ladder; Gibco BRL). The fragment indicated by a black dot
on the left of each panel is 800 bp long.
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had to be removed prematurely despite prompt and adequate
treatment with vancomycin (2, 24). This contrasted sharply with
other studies in the literature in which much lower rates of
CRI were observed and in which only 30% or fewer catheters
had to be removed in the course of a CRI (1, 6, 7, 26, 29, 37).
As 94% of the two predominant strains were ciprofloxacin
resistant and all patients received selective antimicrobial pro-
phylaxis with ciprofloxacin, these strains possessed a selective
advantage. Perhaps subinhibitory concentrations of ciprofloxa-
cin are able to promote adherence of these two S. epidermidis
clones, as has been described recently for S. aureus (4). How-
ever, in earlier studies, adherence of a variety of CoNS strains
was reduced after incubation with subinhibitory concentrations
of ciprofloxacin (38). Furthermore, the pathogenic route in the
development of CRI was shown to be different than those
found in other studies: in 75% of cases, the most likely source
of CRI in this patient group was the exit site skin, while in only
two patients could the hub have played a role (18, 37).
In the study of the epidemiology and dynamics of CoNS
infections in this neutropenic patient population, genotyping
procedures by RAPD and PFGE were shown to be of more
value than phenotyping procedures such as species determina-
tion by API-Staph 32 and study of antibiotic resistance patterns
(8, 33, 34). All but one of bloodstream isolates were identified
as S. epidermidis, and antibiotic resistance patterns varied
widely, not only between different CoNS genotypes but also
within a single genotype. From these results, we conclude that
such phenotyping procedures are of little use in determining
the pathogenesis and epidemiology of CoNS infection. RAPD
and PFGE had about the same discriminating power: PFGE
detected 15 different genotypes, and RAPD detected 14 dif-
ferent genotypes. Also, RAPD and PFGE showed concordant
results in 75% of cases for all genotypes and in 100% of cases
involving RAPD type A-D and PFGE type D.
In our opinion, therefore, RAPD and PFGE are preferred
over biotyping, determining antibiotic resistance patterns, bac-
teriophage typing, sodium dodecyl sulfate-polyacrylamide gel
electrophoresis protein profiles, and plasmid profile analysis
(11, 22). Although plasmid profile analysis is a simple method
that is useful for initial differentiation among isolates, strains
readily lose and acquire plasmids, as is also reflected by the
diversity in antibiotic resistance patterns, thus yielding mis-
leading results in comparisons of isolates over time (22). More-
over, RAPD and PFGE are easy to perform and, like blotting
procedures (22), yield reproducible results over time. Further-
more, as has been shown before, RAPD and PFGE can be
used in combination to increase their discriminatory power
(33, 34).
In conclusion, two virulent clones of S. epidermidis were
shown to be involved in 70% of CRI. These two clones have
expanded for at least the last 5 years in our hematology de-
partment. Their prevalence may in part be related to the in-
troduction in 1987 of ciprofloxacin as part of the selective
antimicrobial prophylaxis of neutropenic hemato-oncologic
patients. Apparently, certain strains of CoNS have the capa-
bility of firmly establishing themselves among certain groups of
critically ill patients in a given geographical setting. Analysis of
virulence determinants that provide this selective advantage
(adhesins for catheter plastic, capacity to effectively form bio-
films, and slime and toxin production, etc.) is the focus of
further research.
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